Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Non-Small Cell Lung Cancer

NCT00150657 is registered in ClinicalTrials.gov with St. John Providence Health System as lead sponsor.

NCT NCT00150657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00150657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Non-Small Cell Lung Cancer
Lead sponsor
St. John Providence Health System
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2004
Completion date
Not reported
Enrollment
45
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer